Results 141 to 150 of about 445,817 (266)

Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema

Clinical Ophthalmology, 2011
Francesco Bandello1, Umberto De Benedetto1, Karl Anders Knutsson1, Maurizio Battaglia Parodi1, Maria Lucia Cascavilla1, Pierluigi Iacono21Department of Ophthalmology, University Vita-salute, Scientific Institute San Raffaele, Milan, Italy; 2Fondazione G ...
Bandello F, De Benedetto U, Knutsson KA, Battaglia Parodi M, Cascavilla ML, Iacono P   +5 more
doaj  

Three hundred sixty‐degree prophylactic laser retinopexy versus focal laser during rhegmatogenous retinal detachment repair: A systematic review and meta‐analysis

Acta Ophthalmologica, Volume 104, Issue 7, Page 731-741, November 2026.
Abstract Purpose To compare the anatomic, functional and safety outcomes of intra‐operative 360‐degree prophylactic laser retinopexy versus focal laser retinopexy during pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD) and to assess the certainty of evidence.
Luke Yaldo, Albert Ting, Saif Pasha, Kyle Sporn, Abdelaziz Abdelaal, Joshua Ong   +5 more
wiley   +1 more source

Triamcinolona subtenoniana en el edema macular diabético Subtenon triamcinolone in the diabetic macular edema

Revista Cubana de Oftalmología, 2009
INTRODUCCIÓN: La prevalencia de la retinopatía diabética está determinada por el tipo de diabetes mellitus y por el tiempo de evolución de la enfermedad.
Eddy Mesa Hernández, Odalis González Peña, Isabel Medina Rodríguez, Rafael González Díaz, Emoe Pérez Muñoz   +4 more
doaj  

Adult‐onset Coats disease: A systematic review and meta‐analysis of imaging biomarkers and targeted therapies

Acta Ophthalmologica, Volume 104, Issue 7, Page e724-e744, November 2026.
Abstract Coats disease diagnosed in adulthood is a rare idiopathic retinal telangiectatic vasculopathy that may differ in phenotype from childhood‐diagnosed cases. This systematic review synthesizes current evidence to characterize its clinical spectrum, imaging features, treatment outcomes and underlying mechanisms, with a focus on immunovascular ...
Catarina Francisco, Nisa Silva, Camiel J. F. Boon   +2 more
wiley   +1 more source

Comparative Efficacy and Safety of Systemic Immunomodulatory Therapies for Non‐Infectious Uveitis: A Systematic Review With Pairwise and Network Meta‐Analyses [PDF]

Pharmacotherapy
ABSTRACT Introduction Non‐infectious uveitis (NIU) is a chronic immune‐mediated ocular inflammatory disease that may cause irreversible visual impairment. The comparative efficacy and safety of systemic immunomodulatory therapies, including conventional agents and biologics, remain incompletely defined.
Chen K, Chan H, Chan C.
europepmc   +2 more sources

Paraneoplastic and Autoimmune Retinopathy Presenting as Isolated Neuro‐Ophthalmic Dysfunction: Two Cases

Clinical and Experimental Neuroimmunology, Volume 17, Issue 4, November 2026.
ABSTRACT Background Paraneoplastic and autoimmune retinopathies can cause progressive visual loss before structural ophthalmic or neurologic findings are diagnostic. Case Presentation A 66‐year‐old woman developed bilateral visual decline and was diagnosed with small‐cell lung cancer‐associated paraneoplastic neuroretinal dysfunction, with persistent ...
Alan B. Dogan, Dean Neutel, Anthony L. Loschner   +2 more
wiley   +1 more source

[Work reintegration in patients treated for diabetic macular edema]. [PDF]

Rev Med Inst Mex Seguro Soc
Peña-Durán SM, Trujillo-Sánchez GP, López-Montero LM.   +2 more
europepmc   +1 more source

Health, hope and worry: A qualitative study of people with diabetes' experiences with anti‐VEGF treatment

Diabetic Medicine, Volume 43, Issue 11, November 2026.
Abstract Aims Diabetic macular edema (DME) is a leading cause of vision loss among individuals with diabetes. While anti‐VEGF therapy is a widely used and effective treatment, limited research has explored participants' lived experiences throughout the treatment process.
J. K. Leksell, E. Granstam, T. Granström, E. Nerpin   +3 more
wiley   +1 more source

Macular edema in retinal fundus images by a computational algorithm [PDF]

Rev Med Inst Mex Seguro Soc
Garrido-Pino CA, López-Montero LM, López-Lozano L, Hernández-González MA, Cruz-Aceves I.   +4 more
europepmc   +1 more source

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real‐Life Experience From a National Reference Network

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10318-10329, November 2026.
ABSTRACT Aim Lipodystrophy syndromes are rare diseases with metabolic and cardiovascular consequences. This study explores the metabolic and renal effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with genetic lipodystrophy. Patients and Methods Patients with familial partial lipodystrophy (n = 57) or congenital generalised ...
Léna Robert, Ines Belalem, Corinne Vigouroux, Hippolyte Dupuis, Marie Christine Vantyghem, Mathilde Simonson, Estelle Nobecourt, Héléna Mosbah, Sophie Beliard, Stéphanie Jellimann, Sonja Janmaat, Camille Vatier, Sophie Lamothe   +12 more
wiley   +1 more source